The Association of Private Hospitals of Malaysia (APHM) is set to present findings from an independent study on medical cost inflation to the Health Ministry next month. The study, commissioned last year, is part of APHM’s efforts to develop evidence-based and sustainable strategies to address the rising costs of healthcare in the country.

A 2023 report by Bank Negara Malaysia revealed that the country’s medical inflation rate was 12.6%, more than double the global average of 5.6%. However, APHM clarified that the figure for private hospitals does not necessarily reflect true year-on-year inflation, as it often represents broader increases in healthcare expenses rather than specific cost changes for identical items or services.

To promote cost transparency, APHM has recommended that its member hospitals adopt drug price transparency in outpatient departments by April 2025. This initiative aligns with the Health Ministry’s ongoing strategies to manage healthcare costs more effectively. 

APHM also commended the collaborative efforts between private hospitals and the government during the Covid-19 pandemic. Initiatives such as public-private partnerships and treatment outsourcing through ProtectHealth Corporation were highlighted as examples of effective cooperation that benefited patients.

Reaffirming its position, APHM stated that private hospitals in Malaysia remain committed to supporting the Health Ministry in alleviating the burden of patient care. The association also emphasised its ongoing dedication to fostering partnerships and implementing measures that contribute to a more sustainable and efficient healthcare system.

(Source: NST) 

• TAGS:
• APHM
• Association of Private Hospitals of Malaysia
• Medical
• Medical Inflation